Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Immuron Limited (IMC.AX)

Compare
0.0670
+0.0010
+(1.52%)
At close: 4:10:17 PM GMT+10
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
4,902.8650
4,902.8650
1,804.7050
765.1930
145.7760
Cost of Revenue
1,566.0680
1,566.0680
495.5580
241.6910
51.0710
Gross Profit
3,336.7970
3,336.7970
1,309.1470
523.5020
94.7050
Operating Expense
8,552.6360
8,552.6360
4,715.6670
3,640.9150
8,048.2130
Operating Income
-5,215.8390
-5,215.8390
-3,406.5200
-3,117.4130
-7,953.5080
Net Non Operating Interest Income Expense
320.1800
320.1800
106.6710
15.6010
-4.5570
Other Income Expense
-2,041.2980
-2,041.2980
-486.6580
247.5580
-426.4000
Pretax Income
-6,936.9570
-6,936.9570
-3,786.5070
-2,854.2540
-8,384.4650
Net Income Common Stockholders
-6,936.9570
-6,936.9570
-3,786.5070
-2,854.2540
-8,384.4650
Diluted NI Available to Com Stockholders
-6,936.9570
-6,936.9570
-3,786.5070
-2,854.2540
-8,384.4650
Basic EPS
-0.03
--
-0.02
-0.01
-0.04
Diluted EPS
-0.03
--
-0.02
-0.01
-0.04
Basic Average Shares
227,860.6410
--
228,102.8310
227,579.6840
221,062.2290
Diluted Average Shares
227,860.6410
--
228,102.8310
227,579.6840
221,062.2290
Total Operating Income as Reported
-5,801.1180
-5,801.1180
-3,568.8380
-2,869.8550
-8,379.9080
Rent Expense Supplemental
24.1220
24.1220
--
--
--
Total Expenses
10,118.7040
10,118.7040
5,211.2250
3,882.6060
8,099.2840
Net Income from Continuing & Discontinued Operation
-6,936.9570
-6,936.9570
-3,786.5070
-2,854.2540
-8,384.4650
Normalized Income
-6,351.6780
-6,351.6780
-3,624.1890
-3,101.8120
-7,958.0650
Interest Income
327.7560
327.7560
116.3230
21.7850
9.2040
Interest Expense
7.5760
7.5760
9.6520
6.1840
13.7610
Net Interest Income
320.1800
320.1800
106.6710
15.6010
-4.5570
EBIT
-6,929.3810
-6,929.3810
-3,776.8550
-2,848.0700
-8,370.7040
EBITDA
-6,883.4000
-6,883.4000
-3,728.1930
-2,805.4640
-8,327.0420
Reconciled Cost of Revenue
1,566.0680
1,566.0680
495.5580
241.6910
51.0710
Reconciled Depreciation
45.9810
45.9810
48.6620
42.6060
43.6620
Net Income from Continuing Operation Net Minority Interest
-6,936.9570
-6,936.9570
-3,786.5070
-2,854.2540
-8,384.4650
Total Unusual Items Excluding Goodwill
-585.2790
-585.2790
-162.3180
247.5580
-426.4000
Total Unusual Items
-585.2790
-585.2790
-162.3180
247.5580
-426.4000
Normalized EBITDA
-6,298.1210
-6,298.1210
-3,565.8750
-3,053.0220
-7,900.6420
6/30/2021 - 4/30/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PAB.AX Patrys Limited
0.0020
0.00%
 
BIT.AX Biotron Limited
0.0020
-33.33%
 
BTC.AX BTC Health Limited
0.0500
0.00%
 
PTX.AX Prescient Therapeutics Limited
0.0420
+2.44%
 
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
 
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
 
CVALF Covalon Technologies Ltd.
1.6300
-2.40%
 
RNV.AX RENERVE FPO [RNV]
0.1100
-4.35%
 
TRP.AX Tissue Repair Ltd
0.2350
-4.08%
 
IOT.V Innovotech Inc.
0.1400
0.00%